Erasca Added to the Nasdaq Biotechnology Index

NEXT STORY
RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase™
PREV STORY
By 2028, Global Demand for Tissue Nano Transfection Market Will Surpass USD 7.06 Billion at 16.6% CAGR Growth: Says Vantage Market Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chembio Diagnostics Announces 2019 Analyst and Investor Meeting

MEDFORD, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a ...

author_avatar
NASDAQ Market News

Altimmune Restructures Financing Agreement

GAITHERSBURG, Md., June 22, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics ...

author_avatar
NASDAQ Market News

Apricus Biosciences Announces $10 Million Registered Direct Offering

SAN DIEGO, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

author_avatar
NASDAQ Market News